Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Protean navigated a soft September by adding to beaten-down MedTech positions on conviction and covering highly profitable investment company shorts, remaining focused on nimble portfolio adjustments.
Full Quick Take
Protean navigated a soft September by adding to beaten-down MedTech positions on conviction and covering highly profitable investment company shorts, remaining focused on nimble portfolio adjustments.
